Muutke küpsiste eelistusi

E-raamat: AI and Drug Development: Opportunities, Privacy and Challenges

  • Formaat: PDF+DRM
  • Ilmumisaeg: 24-Nov-2025
  • Kirjastus: Routledge
  • Keel: eng
  • ISBN-13: 9781040566725
  • Formaat - PDF+DRM
  • Hind: 59,79 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
  • Raamatukogudele
  • Formaat: PDF+DRM
  • Ilmumisaeg: 24-Nov-2025
  • Kirjastus: Routledge
  • Keel: eng
  • ISBN-13: 9781040566725

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

This important book shines a light on the potential benefits of artificial intelligence (AI) to support advances in drug discovery and development, while also highlighting critical issues around patient confidentiality and ethical practice.

In an era of rapid technological advancement, the book offers a comprehensive assessment of both the challenges and opportunities that AI offers the pharmaceutical sector, explaining how AI and machine learning can support the drug development research process. Illustrated with international case studies that demonstrate how these technologies have already been used to help develop new therapeutic possibilities, it also offers a discussion of ethical concerns around privacy and data protection. By thus taking into account both the technological and ethical issues of AI, the book seeks to present a fair and impartial perspective on the role of AI in further global healthcare.

The book will interest to students and researchers across the Health Science, but particularly in Pharmacy, Pharmacology and related fields, as well as those concerned with AI itself. It will also appeal to practicing pharmacists and pharmacologists working in drug research and development.



This important book shines a light on the potential benefits of artificial intelligence (AI) to support advances in drug discovery and development, while also highlighting critical issues around patient confidentiality and ethical practice.

1.Introduction to AI in Drug Discovery. 2.AI Technologies and Tools in
Drug Discovery. 3.Data Collection and Management for AI in Drug Discovery.
4.AI-Driven Drug Target Identification. 5.AI in Drug Design and Optimization.
6.Preclinical and Clinical Development Using AI. 7.Regulatory Considerations
and Ethical Implications. 8.Case Studies of AI in Drug Discovery. 9.Future
Trends in AI-Powered Drug Discovery. 10.Practical Applications and Strategies
for Implementation.
Shaik Aminabee, Professor and Head, Department of Pharmacology, Vallabhaneni Venkatadri Institute of Pharmaceutical Sciences, Gudlavalleru, Krishna District, Andhra Pradesh, India.

Atmakuri Lakshmana Rao, Professor and Principal, Vallabhaneni Venkatadri Institute of Pharmaceutical Sciences, Gudlavalleru, Krishna District, Andhra Pradesh, India.